
Shasqi
Shasqi is a YC Winter 2015 (W15) company. Based in San Francisco, CA, USA; Remote. Team of 28.
About Shasqi
Summary
Shasqi develops cancer therapeutics using its CAPAC platform, which applies click chemistry to activate treatment directly at the tumor site. A click chemistry reagent is localized in the tumor; when a systemically infused prodrug reaches it, the two react and release an active therapy at the target. This confines the therapeutic effect to the tumor while holding systemic exposure below toxic levels, replacing the blunt-force toxicity of conventional chemotherapy.
From the Y Combinator listing
Targeting Cancer with Click Chemistry
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA; Remote
- 28
- Active
- Growth
Founders (1)
- Jose M. Mejia Oneto
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works